Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9B3M8
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 135 | 139 | PF00656 | 0.383 |
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.471 |
CLV_PCSK_KEX2_1 | 147 | 149 | PF00082 | 0.409 |
CLV_PCSK_KEX2_1 | 250 | 252 | PF00082 | 0.487 |
CLV_PCSK_PC1ET2_1 | 147 | 149 | PF00082 | 0.438 |
CLV_PCSK_PC1ET2_1 | 250 | 252 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 144 | 148 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 250 | 254 | PF00082 | 0.468 |
CLV_PCSK_SKI1_1 | 33 | 37 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 62 | 66 | PF00082 | 0.299 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.301 |
DEG_APCC_DBOX_1 | 61 | 69 | PF00400 | 0.298 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.392 |
DOC_MAPK_DCC_7 | 248 | 257 | PF00069 | 0.400 |
DOC_MAPK_gen_1 | 248 | 257 | PF00069 | 0.444 |
DOC_MAPK_MEF2A_6 | 248 | 257 | PF00069 | 0.400 |
DOC_PP1_RVXF_1 | 106 | 112 | PF00149 | 0.299 |
DOC_PP2B_LxvP_1 | 265 | 268 | PF13499 | 0.381 |
DOC_PP4_FxxP_1 | 110 | 113 | PF00568 | 0.578 |
DOC_USP7_MATH_1 | 122 | 126 | PF00917 | 0.308 |
DOC_USP7_MATH_1 | 164 | 168 | PF00917 | 0.605 |
DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.692 |
DOC_WW_Pin1_4 | 297 | 302 | PF00397 | 0.472 |
LIG_14-3-3_CanoR_1 | 11 | 16 | PF00244 | 0.402 |
LIG_14-3-3_CanoR_1 | 203 | 210 | PF00244 | 0.495 |
LIG_14-3-3_CanoR_1 | 33 | 42 | PF00244 | 0.411 |
LIG_14-3-3_CanoR_1 | 86 | 91 | PF00244 | 0.428 |
LIG_Actin_WH2_2 | 226 | 241 | PF00022 | 0.508 |
LIG_CSL_BTD_1 | 110 | 113 | PF09270 | 0.332 |
LIG_deltaCOP1_diTrp_1 | 7 | 15 | PF00928 | 0.376 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.420 |
LIG_FHA_1 | 128 | 134 | PF00498 | 0.379 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.367 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.362 |
LIG_FHA_2 | 80 | 86 | PF00498 | 0.360 |
LIG_FHA_2 | 89 | 95 | PF00498 | 0.289 |
LIG_HCF-1_HBM_1 | 74 | 77 | PF13415 | 0.360 |
LIG_LIR_Gen_1 | 167 | 177 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 196 | 204 | PF02991 | 0.374 |
LIG_LIR_Nem_3 | 167 | 173 | PF02991 | 0.356 |
LIG_LIR_Nem_3 | 196 | 200 | PF02991 | 0.364 |
LIG_Rb_LxCxE_1 | 188 | 205 | PF01857 | 0.471 |
LIG_SH2_CRK | 197 | 201 | PF00017 | 0.479 |
LIG_SH2_CRK | 61 | 65 | PF00017 | 0.442 |
LIG_SH2_NCK_1 | 197 | 201 | PF00017 | 0.414 |
LIG_SH2_NCK_1 | 299 | 303 | PF00017 | 0.370 |
LIG_SH2_NCK_1 | 77 | 81 | PF00017 | 0.431 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.452 |
LIG_SH2_STAT5 | 176 | 179 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 197 | 200 | PF00017 | 0.339 |
LIG_SH2_STAT5 | 299 | 302 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.484 |
LIG_SH3_3 | 109 | 115 | PF00018 | 0.489 |
LIG_Sin3_3 | 95 | 102 | PF02671 | 0.417 |
LIG_WRC_WIRS_1 | 87 | 92 | PF05994 | 0.467 |
MOD_CK1_1 | 218 | 224 | PF00069 | 0.544 |
MOD_CK2_1 | 88 | 94 | PF00069 | 0.280 |
MOD_GlcNHglycan | 123 | 127 | PF01048 | 0.585 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.415 |
MOD_GlcNHglycan | 204 | 207 | PF01048 | 0.585 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.457 |
MOD_GlcNHglycan | 260 | 263 | PF01048 | 0.404 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.392 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.565 |
MOD_LATS_1 | 31 | 37 | PF00433 | 0.465 |
MOD_NEK2_1 | 132 | 137 | PF00069 | 0.397 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.403 |
MOD_NEK2_1 | 256 | 261 | PF00069 | 0.416 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.524 |
MOD_OFUCOSY | 194 | 199 | PF10250 | 0.441 |
MOD_PIKK_1 | 127 | 133 | PF00454 | 0.297 |
MOD_PKA_1 | 33 | 39 | PF00069 | 0.458 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.435 |
MOD_PKA_2 | 202 | 208 | PF00069 | 0.532 |
MOD_Plk_1 | 195 | 201 | PF00069 | 0.519 |
MOD_Plk_2-3 | 175 | 181 | PF00069 | 0.313 |
MOD_Plk_4 | 11 | 17 | PF00069 | 0.386 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.518 |
MOD_Plk_4 | 286 | 292 | PF00069 | 0.510 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.319 |
MOD_ProDKin_1 | 297 | 303 | PF00069 | 0.358 |
TRG_DiLeu_BaEn_1 | 272 | 277 | PF01217 | 0.496 |
TRG_DiLeu_BaEn_1 | 37 | 42 | PF01217 | 0.349 |
TRG_DiLeu_BaEn_1 | 94 | 99 | PF01217 | 0.427 |
TRG_DiLeu_BaLyEn_6 | 248 | 253 | PF01217 | 0.449 |
TRG_ENDOCYTIC_2 | 197 | 200 | PF00928 | 0.454 |
TRG_ENDOCYTIC_2 | 61 | 64 | PF00928 | 0.430 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I587 | Leptomonas seymouri | 62% | 99% |
A0A0S4KI40 | Bodo saltans | 45% | 100% |
A0A1X0P0R2 | Trypanosomatidae | 42% | 100% |
A0A3R7LX07 | Trypanosoma rangeli | 45% | 100% |
A0A3S7X6G1 | Leishmania donovani | 89% | 99% |
A4HL85 | Leishmania braziliensis | 82% | 100% |
A4I8R3 | Leishmania infantum | 89% | 99% |
D0A4Q2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
Q4Q4F9 | Leishmania major | 90% | 100% |
V5BKA1 | Trypanosoma cruzi | 42% | 100% |